Odyssey Health (ODYY) EBIT Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -3.76% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.39% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.70% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.88% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 7.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 34.83% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 75.54% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.70% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -24.91% |
| 10 | Odyssey Health | - | - | - | 50.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 50.35% |
| Oct 31, 2025 | 47.35% |
| Jul 31, 2025 | 56.06% |
| Apr 30, 2025 | 64.43% |
| Jan 31, 2025 | 57.05% |
| Oct 31, 2024 | 25.99% |
| Jul 31, 2024 | 27.88% |
| Apr 30, 2024 | 68.66% |
| Jan 31, 2024 | -22.23% |
| Oct 31, 2023 | 12.89% |
| Jul 31, 2023 | 17.26% |
| Apr 30, 2023 | -8.05% |
| Jan 31, 2023 | -43.81% |
| Oct 31, 2022 | -16.25% |
| Jul 31, 2022 | 57.19% |
| Apr 30, 2022 | -298.82% |
| Jan 31, 2022 | -180.26% |
| Oct 31, 2021 | -201.02% |
| Jul 31, 2021 | -217.08% |
| Apr 30, 2021 | -495.06% |
| Jan 31, 2021 | -39.84% |
| Oct 31, 2020 | -119.75% |
| Jul 31, 2020 | -179.02% |
| Apr 30, 2020 | -128.85% |
| Jan 31, 2020 | -167.77% |
| Oct 31, 2019 | -336.46% |
| Jul 31, 2019 | -810.15% |
| Apr 30, 2019 | -143.65% |
| Jan 31, 2019 | -82.63% |
| Oct 31, 2018 | -28.53% |
| Jul 31, 2018 | -50.59% |
| Apr 30, 2018 | -10.64% |
| Jan 31, 2018 | -67.32% |
| Oct 31, 2017 | -7.28% |